2PKS image
Entry Detail
PDB ID:
2PKS
Title:
Thrombin in complex with inhibitor
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2007-04-18
Release Date:
2008-04-22
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.25
R-Value Work:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Thrombin light chain
Chain IDs:A
Chain Length:27
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Thrombin heavy chain fragment
Chain IDs:B
Chain Length:147
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Thrombin heavy chain fragment
Chain IDs:C
Chain Length:102
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Hirudin
Chain IDs:D
Chain Length:10
Number of Molecules:1
Biological Source:
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
TYS D TYR O-SULFO-L-TYROSINE
Primary Citation
Design, synthesis and biological evaluation of thrombin inhibitors based on a pyridine scaffold.
Org.Biomol.Chem. 5 2599 2605 (2007)
PMID: 18019535 DOI: 10.1039/b705344d

Abstact

A series of 2,4-disubstituted pyridine derivatives has been designed, synthesised and evaluated as thrombin inhibitors. A Grignard exchange reaction was used to introduce various benzoyl substituents in position 4 of the pyridine ring, where they serve as P3 residues in binding to thrombin. In position 2 of the pyridine ring, a para-amidinobenzylamine moiety was incorporated as P1 residue by an SNAr reaction using ammonia as nucleophile followed by a reductive amination. A crystal structure obtained for one of the compounds in the active site of thrombin revealed that the basic amidine group of the inhibitor was anchored to Asp 189 at the bottom of the S1 pocket. A comparison with melagatran, bound in the active site of thrombin, revealed a good shape match but lack of hydrogen bonding possibilities in the S2-S3 region for the thrombin inhibitors reported in this study.

Legend

Protein

Chemical

Disease

Primary Citation of related structures